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Yap Functions Via TEAD Mediated Transcriptional Activation
in Hepatoblastoma Pathogenesis
Pin Liu1,2, Junyan Tao3,4,5, Jie Zhang1,2, Sucha Singh3,4,5, Na Zhan3,4,6, Satdarshan P. S.
Monga3,4,5 , Xin Chen1,2
1Department

of Bioengineering and Therapeutic Sciences and 2Liver Center, University
California, San Francisco, CA; 3Department of Pathology, 4Pittsburgh Liver Research
Center, and 5University of Pittsburgh, School of Medicine and University of Pittsburgh
Medical Center, Pittsburgh, PA, USA; 6Department of pathology, Renmin Hospital of
Wuhan University, Wuhan, China.

Hepatoblastoma (HB) is the most common pediatric liver tumor. Activation of Wnt/βcatenin pathway is considered to be the driver genetic event in HB. In addition to Wnt/βcatenin, activation of Yap is found in a majority of HBs, and high Yap transcriptional
activity was recently found to be associated with high risk HB. Importantly, our studies
demonstrated the coordinated activation of β-catenin and Yap led to HB formation in
mice. However, how Yap functions to promote HB formation remains unknown. Yap has
been shown to have transcriptional activity as well as non-transcriptional based
functions. Here we investigated whether TEAD mediated transcription is the major
mechanism by which Yap promotes HB formation. Specifically, we blocked Yap
transcriptional activity via dominant negative form of TEAD2 (dnTEAD2). We found that
overexpression of dnTEAD2 inhibited HB cell growth in culture and blocked Yap/βcatenin induced HB formation in mice. We generated TEAD2-VP16 fusion construct
which allows TEAD dependent transcriptional activation independent of Yap. When
TEAD2-VP16 was co-expressed with activated β-catenin into mice, it led to HB
formation. Further analysis demonstrated that TEAD2-VP16/β-catenin HBs shared
similar molecular features with Yap/β-catenin tumors. As there are multiple TEADs
(TEAD1, 2, 3 and 4) which share redundant functions, we tested the contribution of
each TEAD in regulating Yap activity in HB cells. We found that silencing of TEAD4
consistently reduced Yap downstream gene expression, supporting that TEAD4 may be
the major Yap partner in HB development. In summary, our studies support that Yap
predominantly regulates HB development via TEAD4 mediated transcriptional activation,

and blocking Yap/TEAD interaction may represent a novel therapeutic strategy against
HB.
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